FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113274198> ?p ?o ?g. }

• W3113274198 abstract "Background: Complement system is one of ancient innate immune systems in our body fighting against pathogens and foreign bodies. Either one of its three pathways, classical, alternative or lectin activates it. Because of its role and importance in combating against different pathological conditions, it works through defined proteins including regulators and inhibitors. However, over or under stimulation of complement system can lead to various diseases. A number of analytical assays are used to measure complement proteins and its activation states considering complement 3 (C3), complement 4 (C4) as the most common test used. Objectives: Our aims are to study the clinical utility and cost effectiveness of C3 and C4 among different clinical subspecialties in Hamad Medical Corporation (HMC), Doha-Qatar. Design and methods: A retrospective study was conducted using electronic medical records to generate patient’s list from clinical immunology laboratory at HMC. Data on 326 patients were collected from 1st January till 31st March, 2017 and used as pilot study after omitting duplications. The data was studied for its demographical, disease categories, C3 and C4 test results. C3 and C4 test cost were calculated inside HMC and compared to other healthcare providers in country and abroad. Results: A total of 326 patients, 148 males and 178 females (M/F ratio:0.8:1), of age (mean age ±SD) of 36 ± 17.6 years. 289(86%) were >15 years and 47(14%) were 15 or less. Kidney diseases (34%), autoimmune diseases (25%), and allergic diseases (18%) were the top 3 diseases, and constituted 77% of all diseases. 45/336 (13.4%) showed low C3, C4, or both. Mean levels of C3 (±SD) was 120.8 ±36.3 mg/dl, and C4 was27.85±11.9 mg/dl. High C3 and C4 levels were observed in 53 (15.7%) of patients. The cost of performing one test either C3 or C4 in HMC is 22 QR ($6), while other healthcare providers inside the country costed 150-300 QR ($41.2-$82.4). Conclusion: Autoimmune diseases, renal diseases and joist diseases were the most common diseases with low C3 and C4 levels. Although the cost of a single test of C3 or C4 is low, the total annual cost is huge. The treating physician is recommended to exercise judicious clinical wisdom when ordering C3 or C4 tests as diagnostic tools" @default.
• W3113274198 created "2020-12-21" @default.
• W3113274198 creator A5050882545 @default.
• W3113274198 creator A5052552165 @default.
• W3113274198 creator A5076585377 @default.
• W3113274198 creator A5088418434 @default.
• W3113274198 date "2020-10-28" @default.
• W3113274198 modified "2023-09-23" @default.
• W3113274198 title "Clinical Utility and Cost Effectiveness of Complement 3 and Complement 4 in different Clinical Subspecialties in Hamad Medical Corporation" @default.
• W3113274198 doi "https://doi.org/10.29117/quarfe.2020.0161" @default.
• W3113274198 hasPublicationYear "2020" @default.
• W3113274198 type Work @default.
• W3113274198 sameAs 3113274198 @default.
• W3113274198 citedByCount "0" @default.
• W3113274198 crossrefType "proceedings-article" @default.
• W3113274198 hasAuthorship W3113274198A5050882545 @default.
• W3113274198 hasAuthorship W3113274198A5052552165 @default.
• W3113274198 hasAuthorship W3113274198A5076585377 @default.
• W3113274198 hasAuthorship W3113274198A5088418434 @default.
• W3113274198 hasBestOaLocation W31132741981 @default.
• W3113274198 hasConcept C104317684 @default.
• W3113274198 hasConcept C111684460 @default.
• W3113274198 hasConcept C112313634 @default.
• W3113274198 hasConcept C126322002 @default.
• W3113274198 hasConcept C127716648 @default.
• W3113274198 hasConcept C151730666 @default.
• W3113274198 hasConcept C167135981 @default.
• W3113274198 hasConcept C188082640 @default.
• W3113274198 hasConcept C195910791 @default.
• W3113274198 hasConcept C203014093 @default.
• W3113274198 hasConcept C2777267654 @default.
• W3113274198 hasConcept C55493867 @default.
• W3113274198 hasConcept C71924100 @default.
• W3113274198 hasConcept C86803240 @default.
• W3113274198 hasConcept C8891405 @default.
• W3113274198 hasConceptScore W3113274198C104317684 @default.
• W3113274198 hasConceptScore W3113274198C111684460 @default.
• W3113274198 hasConceptScore W3113274198C112313634 @default.
• W3113274198 hasConceptScore W3113274198C126322002 @default.
• W3113274198 hasConceptScore W3113274198C127716648 @default.
• W3113274198 hasConceptScore W3113274198C151730666 @default.
• W3113274198 hasConceptScore W3113274198C167135981 @default.
• W3113274198 hasConceptScore W3113274198C188082640 @default.
• W3113274198 hasConceptScore W3113274198C195910791 @default.
• W3113274198 hasConceptScore W3113274198C203014093 @default.
• W3113274198 hasConceptScore W3113274198C2777267654 @default.
• W3113274198 hasConceptScore W3113274198C55493867 @default.
• W3113274198 hasConceptScore W3113274198C71924100 @default.
• W3113274198 hasConceptScore W3113274198C86803240 @default.
• W3113274198 hasConceptScore W3113274198C8891405 @default.
• W3113274198 hasLocation W31132741981 @default.
• W3113274198 hasOpenAccess W3113274198 @default.
• W3113274198 hasPrimaryLocation W31132741981 @default.
• W3113274198 hasRelatedWork W11628940 @default.
• W3113274198 hasRelatedWork W13293156 @default.
• W3113274198 hasRelatedWork W13370457 @default.
• W3113274198 hasRelatedWork W19182783 @default.
• W3113274198 hasRelatedWork W19622141 @default.
• W3113274198 hasRelatedWork W20033580 @default.
• W3113274198 hasRelatedWork W4698420 @default.
• W3113274198 hasRelatedWork W9140630 @default.
• W3113274198 hasRelatedWork W16147512 @default.
• W3113274198 hasRelatedWork W21381044 @default.
• W3113274198 isParatext "false" @default.
• W3113274198 isRetracted "false" @default.
• W3113274198 magId "3113274198" @default.
• W3113274198 workType "article" @default.